I am passionate about harnessing data and cutting-edge technologies to optimize the clinical impact of cancer drugs and diagnostics. Drawing from my personal experiences with cancer, I am devoted to developing analytical systems that integrate clinical, imaging, and biomarker data to provide real-time access to high-quality information. Throughout my career, I have worked closely with clinical teams, advocating for data-driven decision-making and uncovering insights into clinical realities. I strongly believe that by leveraging complex datasets, we can gain a deeper understanding of cancer biology, and subsequently improve our decision-making processes. This adaptable approach empowers us to address fundamental questions, such as which targets to pursue, which technologies to invest in, which drugs to prioritize, and ultimately, which therapies are best suited for individual patients.

I work in the System Managers team and currently support the reporting application CART. I am also responsible for the reporting part of Gemstone and currently working on the reports needed for MVP-2. I am located in the UK and have worked at Bayer for 15 years.

I'm part of DS3 group and I work as Process Manager for Technology Application Management

Konrad is a Software Engineer, leads the Automation an Architecture team and is working on the digital transformation.

I am working in DS3 heading a team working in the areas of Medical Standards, Medical Coding and supporting Data Compliance topics.

Originally a Chemist, spent a long time in R&D IT implementing and running systems, engineering requirements, heading projects and teams. Always curious about new technologies and trends. Currently in the Product Owner Hub for Modalities and taking care of some of our large systems for the lab chemists. Still trying to find out what all this NFT stuff should really be good for. But anyway, some people also collect stamps. Or coins.